Key players in the acne medication market are Allergan plc, Galderma SA, Valeant Pharmaceutical International Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson Services Inc., GlaxoSmithKline Plc.
New York, March 16, 2022 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the “Acne Drugs Global Market Report 2022” – https://www.reportlinker.com/p06245001/?utm_source=GNW
Bayer AG, Stiefel Laboratories Inc., Ranbaxy Laboratories Limited, Pfizer Inc., Sun Pharmaceutical Industries Limited, Mayne Pharma Group Limited, Mylan NV, Cipher, Daiichi Sankyo Company, Ltd, Guthy-Renker LLC, Medicis Pharmaceutical Corporation, Foamix Pharmaceuticals, BioPharmX , In, Roche Holding AG, F. Hoffmann-la Roche Ltd, Anterios Inc., AndroScience, Oculus Innovative Sciences, Aqua Pharmaceuticals, Skinvisible Pharmaceuticals and Prestium Pharma Inc.
The global acne medication market is expected to grow from $5.03 billion in 2021 to $5.36 billion in 2022 at a compound annual growth rate (CAGR) of 6.7%. The growth is mainly due to companies reorganizing their operations and recovering from COVID-19. impact, which had previously led to restrictive containment measures involving social distancing, remote working and the closure of business activities which resulted in operational challenges. The market is expected to reach $6.55 billion in 2026 with a CAGR of 5.2%.
The acne medications market includes sales of prescription acne medications (salicylic acid, Retin-A Micro, Onexton and Solodyn) and related over-the-counter products (cleansers, lotions, gels, toners, masks and pads containing anti-acne ingredients) which are used to treat skin conditions such as acne vulgaris medications and acne rosacea medications. The market in this report does not include sales of drugs used for dermatitis and psoriasis.
An increase in people’s disposable income is one of the major drivers of the acne medication market. An increase in disposable income is usually due to an improvement in the economy leading to an increase in wages and salaries which stimulates health expenditure.
According to the Office For National Statistics (UK), in 2020 the average household disposable income in the UK was £30,800 ($37,830), an increase of 2.3% from 2019. Rising disposable income and rising spending on facial care products is expected to continue, driving the market during the forecast period.
North America was the largest region in the acne medication market in 2021. The Middle East is expected to be the fastest growing region during the forecast period.
Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Acne medications are a major problem all over the world, nearly 90% of people suffer from some sort of acne medication. In America alone, nearly 12 million people suffer from a serious acne medication problem, which can lead to scarring of the skin if left untreated. Therefore, many people buy medications and acne care products.
The presence of alternatives for acne medication treatment is one of the restraints in the acne medication market. Due to the availability of several alternatives, patients tend to choose one option from many options based on price, side effects, duration and many more.
This increases the competition and as a result the competition reduces a major share of the acne medication market business. For example, some of the alternatives for acne medication treatment apart from acne medication are Ayurveda, home remedies, laser and photodynamic therapy and whitehead and blackhead extraction at using special tools like needles and forceps.
Combination therapy is the latest trend in the acne medication market. Combination therapy is the process of combining two drugs with different mechanisms of action, such drug combinations have better efficacy and adherence compared to monotherapy (the use of a single drug by itself ).
The combination of a topical retinoid drug, which unclogs pores, and an antimicrobial drug, which is used to treat an infection, is used to treat acne medication. An example of combination therapy includes: Epiduo, Acanya, Ziana and Benzamycin produced by Galderma, Allergan, Medicis and Atrix respectively.
Strict regulations regarding the use of drugs to treat acne medication are impacting the acne medication market. Regulations have become strict due to various side effects and adverse events caused during treatment.
In India, the Central Drugs Standard Control Organization (CDSCO) has issued a warning regarding safety guidelines for the use of the oral drug, isotretinoin. make end users aware of the serious birth defects the drug can cause.
In addition, the Expert Committee on Dermatology and Allergy has recommended that the drug should only be sold with a prescription from a dermatologist, that manufacturers provide a leaflet in local languages and that retail pharmacists retain details. of the retail sale of drugs. Hence, these stringent guidelines and regulations would impact the growth of the acne medication market.
In March 2019, Allergan acquired Envy Medical Inc. o for an undisclosed price. This agreement will help Allergan further its goal of providing customers with improved skincare solutions. Envy medicals technology used in skin resurfacing procedures like Dermalinfusion, which is a non-surgical, non-invasive skin resurfacing system, will greatly help Allergan gain a strong foothold in the acne medicine market. . Allergan plc is a pharmaceutical company established in 1948 and based in Dublin, Ireland.
Countries covered in the Acne Drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea South, the United Kingdom and the United States.
Read the full report: https://www.reportlinker.com/p06245001/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001